Shigeyoshi Saito Selected Research

Shigeyoshi Saito Research Topics

Disease

8	Neoplasms (Cancer) 04/2022 - 01/2011
3	Glioblastoma (Glioblastoma Multiforme) 04/2022 - 10/2010
3	Fibrosis (Cirrhosis) 01/2022 - 01/2016
3	Mitochondrial Diseases (Mitochondrial Disease) 06/2019 - 01/2019
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2022
2	Hypoxia (Hypoxemia) 01/2021 - 01/2019
2	Ischemia 01/2021 - 01/2020
2	Brain Neoplasms (Brain Tumor) 10/2019 - 10/2010
2	Body Weight (Weight, Body) 07/2013 - 01/2012
2	Mesothelioma 05/2011 - 01/2011
1	Hepatic Encephalopathy 04/2022
1	Hypertrophy 01/2022
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022
1	Fatty Liver 01/2022
1	Inflammation (Inflammations) 01/2022
1	Tachycardia (Tachyarrhythmias) 01/2022
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2021
1	Stroke (Strokes) 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2020
1	Leukemia 04/2020
1	Neuroblastoma 10/2019
1	Breast Neoplasms (Breast Cancer) 10/2019
1	Hemorrhage 10/2019
1	Disease Progression 01/2019
1	Leigh Disease (Leigh's Disease) 01/2019
1	Myocardial Infarction 01/2019
1	Pelizaeus-Merzbacher Disease 02/2012
1	Central Nervous System Diseases (CNS Diseases) 01/2012
1	Malignant Mesothelioma 05/2011
1	Adenocarcinoma of Lung 05/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2011
1	Ovarian Neoplasms (Ovarian Cancer) 01/2011
1	Gliosarcoma 10/2010

Drug/Important Bio-Agent (IBA)

3	Protons (Proton)IBA 04/2022 - 01/2019
3	Lactic Acid (Lactate)FDA LinkGeneric 06/2019 - 01/2019
3	ManganeseIBA 01/2012 - 01/2011
2	APTIBA 04/2022 - 10/2019
2	AmidesIBA 04/2022 - 10/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2011
2	Biomarkers (Surrogate Marker)IBA 03/2019 - 01/2019
2	Contrast MediaIBA 07/2013 - 05/2011
2	Superoxide DismutaseIBA 05/2011 - 01/2011
1	Thioacetamide (Thioacetamid)IBA 04/2022
1	Temozolomide (Temodar)FDA LinkGeneric 04/2022
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 01/2022
1	CalciumIBA 01/2022
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2022
1	CholesterolIBA 01/2022
1	InflammasomesIBA 01/2022
1	Sesame Oil (Oil, Sesame)IBA 01/2022
1	Alprostadil (Muse)FDA LinkGeneric 01/2021
1	Vasodilator Agents (Vasodilators)IBA 01/2021
1	MonocrotalineIBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	Semaxinib (SU5416)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	CreatineIBA 01/2021
1	Therapeutic UsesIBA 04/2020
1	AntigensIBA 04/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2019
1	Hematoxylin (Haematoxylon)IBA 10/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Collagen Type I (Type I Collagen)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 08/2013
1	Epidermal Growth Factor (EGF)IBA 08/2013
1	Ferrosoferric Oxide (Magnetite)FDA Link 08/2013
1	gadolinium ethoxybenzyl DTPA FDA Link 07/2013
1	Cyclin D1IBA 06/2013
1	N-acetylaspartate (N-acetyl aspartate)IBA 02/2012
1	isospaglumic acid (NAAGA)IBA 02/2012
1	antineoplaston A10 (A 10)IBA 01/2012
1	N,N'- bis(pyridoxal- 5- phosphate)ethylenediamine- N,N'- diacetic acid (mangafodipir)FDA Link 05/2011
1	manganese chloride (manganese chloride, tetrahydrate)FDA Link 05/2011
1	AsbestosIBA 05/2011
1	Iron-Binding ProteinsIBA 02/2011
1	Ferritins (Ferritin)IBA 02/2011
1	Neomycin FDA LinkGeneric 01/2011
1	Biological FactorsIBA 01/2011
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2010
1	InterferonsIBA 10/2010
1	Urokinase Plasminogen Activator ReceptorsIBA 10/2010
1	Peptide Hydrolases (Proteases)FDA Link 10/2010

Therapy/Procedure

2	Radiotherapy 06/2013 - 01/2012
1	Drug Therapy (Chemotherapy) 04/2022
1	Heart Transplantation (Grafting, Heart) 01/2022
1	Synchrotrons 01/2021
1	Tourniquets 01/2020
1	Therapeutics 01/2016